Introduction
Genetic amniocentesis remains the most common invasive diagnostic procedure for the detection of chromosomal aberrations in fetuses. The means to diagnose the fetal karyotype has provided medical cytogenetics with one of its major areas of application. The discovery of an abnormality allows the option of termination or, later in the pregnancy, more suitable obstetric management [1, 2] . Here, we report the 10-year experience (1995) (1996) (1997) (1998) (1999) (2000) (2001) (2002) (2003) (2004) of prenatal detection of fetal chromosome aberrations by amniocentesis at Taichung Veterans General Hospital.
Methods
Data were collected at Taichung Veterans General Hospital between 1995 and 2004 for cytogenetic analyses of cultured amniocytes from second-trimester amniocentesis. The main indications for amniocentesis in this study included advanced maternal age, abnormal maternal serum screening results, abnormal ultrasound findings, and several other reasons (e.g. a previous child with congenital anomaly, a family history of chromosome aberration, an abnormally high maternal serum level of -fetoprotein, and prenatal biochemical or molecular referrals). Advanced maternal age was defined as more than 35 years at delivery [3] . Abnormal maternal serum screening tests included pregnant women with highrisk screening results for trisomies 18 and 21. Abnormal ultrasound findings included fetal anomalies and the presence of soft markers indicating the possibility of chromosome aberrations (e.g. increased nuchal fold thickness and bilateral, large choroid plexus cysts). A family history of chromosome aberrations included aneuploidy, translocation, inversion, and marker chromosome. We excluded all elective purposes, including maternal anxiety and maternal serum screening results close to a Down's syndrome risk cut-off level of 1/270 (but still low risk). Chromosome aberrations (numerical and structural) included full aneuploidy, polyploidy, mosaicism, deletion, duplication, insertion, inversion, balanced translocation, unbalanced translocation, ring chromosome, and marker chromosome. Variant chromosomes, such as inversion of chromosome 9 and Y, double satellites or marked satellite on acrocentric chromosomes, and hyperchromatin on chromosomes 1, 9, and 16, were categorized as normal.
Results
From 1995 to 2004, 7,028 amniocenteses were performed and analyzed for chromosome aberrations at Taichung Veterans General Hospital (Table) . Among these, 4,026 (57.29%) were for advanced maternal age, 1,500 (21.34%) for abnormal maternal serum screening results, 553 (7.87%) for abnormal ultrasound findings, and 949 (13.50%) for other reasons. The highest rate of detection of chromosome aberrations was in women undergoing amniocentesis for abnormal ultrasound findings (8.86%), followed by other reasons (2.74%), abnormal maternal serum screening results (2.60%), and advanced maternal age (2.31%).
Chromosome aberrations were detected in 207 cases (2.90%), including 93 with advanced maternal age, 39 with abnormal maternal serum screening results, 49 with abnormal ultrasound findings, and 26 with other reasons. Of cases with chromosome aberrations, 144 (69.56%) had trisomy 13, trisomy 18, trisomy 21, or sex chromosome disorder. There were nine trisomy 13, 24 trisomy 18, 57 trisomy 21 (55 nonmosaic and 2 mosaic), and 54 sex chromosome aberrations (39 non-mosaic and 15 mosaic). The other 63 cases (30.44%) included 29 with balanced translocation (23 parentally inherited, 4 de novo, and 2 mosaic), 19 with unbalanced abnormality (4 parentally inherited, 4 de novo, and 11 mosaic), 10 with inversion (9 parentally inherited and 1 de novo), and five with marker chromosome (4 de novo and 1 mosaic).
Discussion
This study was started after 1995, when maternal serum screening double-marker testing became available at Taichung Veterans General Hospital. Most women underwent genetic amniocentesis for advanced maternal age (57.29%). The detection rate for chromosome disorders was 2.90%, compatible with data from multiple centers [4, 5] . Trisomy 21 was the most common disorder (27.54%), followed by sex chromosome aberration (26.09%). The detection rate among women undergoing amniocentesis for abnormal ultrasound findings (8.86%) was around fourfold higher than that in other women (2-3%).
Based on this study of our 10-year experience of prenatal diagnosis of chromosome disorders, we did not find an apparent change compared with previous reports [4] . However, our data has allowed for the establishment of another database for genetic counseling, and the discovery of an abnormality allows the option of termination or, later in the pregnancy, more suitable obstetric management.
Generally, people who decide to have prenatal diagnosis are concerned about specific chromosomal conditions, the most common of which is Down's syndrome. However, an unexpected abnormality is more likely than the "expected" one. In view of the effective use of amniocentesis as a diagnostic procedure for chromosome aberration, efforts should be made using more efficient prenatal programs to reduce the number of unnecessary amniocenteses.
